Ebitda változás Dátum
Abbott USD 2.41B 132M 2023-12
Agilent USD 456M 18M 2023-12
AtriCure USD -4489000 511K 2023-12
Baxter International USD 780M 31M 2023-12
Becton, Dickinson and Co. USD 1.11B 79M 2023-12
Bio-Rad Laboratories USD 136.77M 6.92M 2023-12
Boston Scientific USD 1.01B 6M 2023-12
Cooper Companies USD 228.4M 17.7M 2023-09
Danaher USD 1.83B 126M 2023-12
Dexcom USD 286M 32.3M 2023-12
Edwards Lifesciences USD 463.9M 6.4M 2023-12
Globus Medical USD 97.94M 11.51M 2023-12
Hologic USD 315.1M 50.8M 2023-12
Insulet USD 125.2M 51.7M 2023-12
Integra LifeSciences USD 101M 11.73M 2023-12
Intuitive Surgical USD 455.3M 134.9M 2023-12
J&J USD 6.46B 1.51B 2023-12
Masimo USD 87.3M 30.6M 2023-12
Merit Medical Systems USD 59.18M 8.32M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
Smith & Nephew USD 612M 5M 2023-06
Stryker USD 1.68B 420M 2023-12
Tandem Diabetes Care USD -31029000 3.51M 2023-12
Teleflex USD 199.11M 24.03M 2023-12
Terumo JPY 55.68B 8.07B 2023-09
Thermo Fisher Scientific USD 2.79B 12M 2023-12
Zimmer Biomet Holdings USD 679.8M 137.7M 2023-12



Abbott - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.